Sleep Apnea Devices Market Worth 6.49 Billion USD by 2023

USA - English

• India - English

PUNE, India, April 20, 2018 /PRNewswire/ --

According to a new market research report "Sleep Apnea Devices Market by Type, (Therapeutic (CPAP, APAP, Masks, ASV, Oral Appliances, Mandibular Advancement Device), Diagnostic (PSG, Oximeter)), End User (Sleep Laboratories & Hospitals, Home Care/Individuals) - Global Forecasts to 2023", published by MarketsandMarkets™, the market is projected to reach USD 6.49 Billion by 2023 from an estimated USD 4.44 Billion in 2018, at a CAGR of 7.8%.

     (Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg )

Browse 229 market data Tables and 33 Figures spread through 226 Pages and in-depth TOC on "Sleep Apnea Devices Market"

" https://www.marketsandmarkets.com/Market-Reports/sleep-apnea-devices-market-719.html

Early buyers will receive 10% customization on this report

Growth in this market can primarily be attributed to factors such as the increasing prevalence of sleep apnea globally owing to the increase of lifestyle diseases like obesity, initiatives by market players and the government to increase awareness regarding sleep apnea, and the various technological advancements brought about by players to make the products comfortable for patients and thus increase patient compliance and adherence to the treatment.

The oral appliances segment to grow at the highest CAGR during the forecast period 

By product, the therapeutic devices segment has been further segmented into positive airway pressure (PAP) devices, facial interfaces (masks), accessories, oral appliances, adaptive servo-ventilators (ASV), and other therapeutic devices (oxygen concentrators and airway clearance systems). Of all these product segments, the oral appliances segment is projected to grow at the highest CAGR during the forecast period. Growth in this segment is largely due to the increasing issues associated with PAP compliance and the advantages of oral appliances over other therapies like enhanced patient comfort, noninvasiveness, small size, and convenience.

Sleep laboratories & hospitals to dominate the Sleep Apnea Devices Market during the forecast period 

The major end users of sleep apnea devices include sleep laboratories & hospitals and home care/individuals. The sleep laboratories & hospitals segment is projected to grow at the highest CAGR during the forecast period. Growth in this segment is largely due to the increasing number of patients undergoing sleep testing at a laboratory or a hospital.

 Ask for PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=719

North America dominated the market in 2017 

North America is expected to account for the largest share of the Sleep Apnea Devices Market in 2018, followed by Europe. The large share of this region can be attributed to the increasing obesity in the US which is in turn increasing the prevalence of sleep apnea, the high growth of the home sleep testing devices, and issuance of grants and funds by private and government institutions to promote awareness of sleep apnea as well as launch novel and technologically advanced products in the market space.

ResMed (US), Koninklijke Philips (Netherlands), and Fisher & Paykel Healthcare (New Zealand) are the key players in the Sleep Apnea Devices Market. Other players involved in this market are SomnoMed (Australia), Compumedics (Australia), Löwenstein Medical (Germany), Whole You (US), BMC Medical (China), Drive DeVilbiss Healthcare (US), and Braebon Medical (Canada).

Know more about the Sleep Apnea Devices Market:  

https://www.marketsandmarkets.com/Market-Reports/sleep-apnea-devices-market-719.html

About MarketsandMarkets™  

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]

Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets

SOURCE MarketsandMarkets